Four nonprofit hospital systems are applying to the FDA for approval to produce and market their own line of generic drugs. The hospitals are looking to produce generics for which there currently isn't much competition. Melanie Evans writes in The Wall Street Journal: The hospitals said they would prioritize production of generic drugs for which the market lacks competition, though they declined to specify which drugs they would produce first. “We have no designs on being a major pharmaceutical power,” Intermountain President and Chief Executive Marc Harrison said. “This is a very specific … [Read more...]